PAR-1 Expression in Chronic Subdural Hematoma: Potential Association with Vascular Permeability

Area of Science:

• Neurosurgery
• Vascular Biology
• Inflammation Research

Background:

• Chronic subdural hematoma (CSDH) is a prevalent neurosurgical condition in the elderly.
• CSDH pathophysiology involves inflammation, neovascularization, and increased vascular permeability.
• The role of protease-activated receptor-1 (PAR-1) in CSDH vascular dysfunction is not well understood.

Purpose of the Study:

• To investigate the expression of PAR-1 in the dura mater and outer membrane of CSDH patients.
• To compare PAR-1 and zonula occludens-1 (ZO-1) expression in CSDH versus control groups.
• To explore the potential of PAR-1 as a biomarker and therapeutic target in CSDH.

Main Methods:

• Immunohistochemistry was used to assess PAR-1 and ZO-1 expression in dura mater and CSDH outer membrane samples.
• mRNA expression analysis was performed to quantify PAR-1 and ZO-1 levels.
• Age- and sex-matched cases (6 CSDH, 5 controls) were analyzed.

Main Results:

• Strong PAR-1 immunoreactivity was observed in the vascular structures of the CSDH outer membrane.
• Dura mater from both CSDH and control groups showed minimal PAR-1 staining.
• ZO-1 expression was preserved in the vasculature of the CSDH outer membrane and control dura mater.
• A trend towards higher PAR-1 and lower ZO-1 mRNA expression in CSDH was noted, but not statistically significant.

Conclusions:

• This study provides the first evidence of PAR-1 expression in the outer membrane of CSDH.
• PAR-1 expression in CSDH suggests a role in promoting local vascular hyperpermeability.
• PAR-1 represents a potential biomarker and therapeutic target for managing CSDH.